Amundi’s Elevance Health ELV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$492M Buy
1,404,180
+320,023
+30% +$112M 0.17% 116
2025
Q1
$491M Sell
1,084,157
-209,645
-16% -$94.9M 0.18% 119
2024
Q4
$496M Sell
1,293,802
-38,706
-3% -$14.8M 0.17% 127
2024
Q3
$652M Sell
1,332,508
-60,870
-4% -$29.8M 0.24% 95
2024
Q2
$739M Buy
1,393,378
+29,896
+2% +$15.9M 0.28% 76
2024
Q1
$715M Sell
1,363,482
-4,262
-0.3% -$2.24M 0.31% 74
2023
Q4
$660M Sell
1,367,744
-144,889
-10% -$69.9M 0.3% 76
2023
Q3
$685M Sell
1,512,633
-4,384
-0.3% -$1.99M 0.34% 62
2023
Q2
$674M Sell
1,517,017
-328,596
-18% -$146M 0.34% 63
2023
Q1
$895M Buy
1,845,613
+8,080
+0.4% +$3.92M 0.48% 36
2022
Q4
$883M Buy
1,837,533
+524,419
+40% +$252M 0.48% 36
2022
Q3
$629M Buy
1,313,114
+462,779
+54% +$222M 0.37% 50
2022
Q2
$397M Sell
850,335
-325,389
-28% -$152M 0.32% 78
2022
Q1
$605M Buy
1,175,724
+144,106
+14% +$74.2M 0.41% 50
2021
Q4
$461M Sell
1,031,618
-56,662
-5% -$25.3M 0.29% 79
2021
Q3
$406M Buy
1,088,280
+311,477
+40% +$116M 0.28% 76
2021
Q2
$297M Buy
+776,803
New +$297M 0.21% 116